NYSE - Delayed Quote USD

Charles River Laboratories International, Inc. (CRL)

Compare

106.05

+1.80

+(1.73%)

At close: April 17 at 4:00:02 PM EDT

106.04

-0.01

(-0.01%)

After hours: April 17 at 6:00:26 PM EDT

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide […]

Insider Monkey yesterday

CRL
+1.73%
COMP
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

WILMINGTON, Mass., April 15, 2025--Charles River Laboratories schedules first-quarter 2025 earnings release and conference call

Business Wire 3 days ago

CRL
+1.73%
Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?

Charles River (CRL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 4 days ago

CRL
+1.73%
ALHC
Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday?

We recently published a list of Traders Heavily Sold Down These 10 Stocks on Thursday. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other stocks that traders heavily sold down on Thursday. The stock market wiped away earlier gains, ending Thursday’s trading in […]

Insider Monkey 8 days ago

CRL
+1.73%
^GSPC
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?

Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 8 days ago

CRL
+1.73%
Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?

Bausch + Lomb (BLCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks 9 days ago

BHC

CRL
+1.73%
Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.

Zacks 19 days ago

CRL
+1.73%
TMO

BIO-B
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform

WILMINGTON, Mass. & CAMBRIDGE, Mass., March 25, 2025--Charles River and Valo Health announce the identification of an advanceable product candidate for treatment of lupus and other autoimmune diseases.

Business Wire 25 days ago

CRL
+1.73%
Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against the other best diagnostics stocks to invest in right now. Overview of the Clinical Diagnostics Market According to a […]

Insider Monkey 25 days ago

CRL
+1.73%
Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?

Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 28 days ago

CRL
+1.73%
CVS
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Medpace (NASDAQ:MEDP) and its peers.

StockStory 29 days ago

CRL
+1.73%
RGEN
3 Reasons CRL is Risky and 1 Stock to Buy Instead

Over the last six months, Charles River Laboratories’s shares have sunk to $173.44, producing a disappointing 15.7% loss while the S&P 500 was flat. This might have investors contemplating their next move.

StockStory 30 days ago

CRL
+1.73%
Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Most readers would already be aware that Charles River Laboratories International's (NYSE:CRL) stock increased...

Simply Wall St. last month

CRL
+1.73%
Charles River Laboratories to Present at Barclays Global Healthcare Conference

WILMINGTON, Mass., March 11, 2025--Charles River Laboratories to Present at Barclays Global Healthcare Conference

Business Wire last month

CRL
+1.73%
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.

StockStory last month

CRL
+1.73%
Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings

Bell Asset Management, an investment management company, released its Q4 2024 “Bell Global Equities Fund” investor letter. A copy of the letter can be downloaded here. A depreciating Australian Dollar boosted returns for local investors, concluding another successful year for equity investors. The MSCI World ex-Australia Index rose 2.6% over December, while the Bell Global […]

Insider Monkey last month

CRL
+1.73%
Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture

Charles River Laboratories International, Inc.'s ( NYSE:CRL ) stock was strong despite it releasing a soft earnings...

Simply Wall St. last month

CRL
+1.73%
SGH and Charles River team up for CGMP cell banking services

SGH will process cord blood to develop and produce allogeneic chimeric antigen receptor (CAR) T-cells designed for cancer treatment.

Hospital Management last month

CRL
+1.73%
Charles River Announces Agreement with Singapore General Hospital

WILMINGTON, Mass., February 25, 2025--Charles River to provide master cell banking and NGS testing services for SGH's cord blood derived allogeneic CAR-T cells.

Business Wire last month

CRL
+1.73%
Deciphering Charles River (CRL) International Revenue Trends

Examine the evolution of Charles River's (CRL) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Zacks last month

CRL
+1.73%

Performance Overview

Return	CRL	S&P 500 (^GSPC)
YTD	-42.55%	-10.18%
1-Year	-53.91%	+5.19%
3-Year	-62.74%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?

Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday?

Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

3 Reasons CRL is Risky and 1 Stock to Buy Instead

Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings

Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture

SGH and Charles River team up for CGMP cell banking services

Charles River Announces Agreement with Singapore General Hospital

Deciphering Charles River (CRL) International Revenue Trends

Performance Overview